Alex A. Henneman

Amsterdam, NH 1081HV, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Phosphoproteomics of Hypertrophic Cardiomyopathy Patient Myocardium and Novel hiPSC-CM Model Reveal Protein Kinase A as a Modulator of Microtubule Repolymerization.

Phosphoproteomics of Hypertrophic Cardiomyopathy Patient Myocardium and Novel hiPSC-CM Model Reveal Protein Kinase A as a Modulator of Microtubule Repolymerization.

Journal: bioRxiv : the preprint server for biology

Published: February 27, 2026

Boosting the Speed and Accuracy of Protein Quantification Algorithms in Mass Spectrometry-Based Proteomics.

Boosting the Speed and Accuracy of Protein Quantification Algorithms in Mass Spectrometry-Based Proteomics.

Journal: Journal of proteome research

Published: January 20, 2026

CellEKT: A Robust Chemical Proteomics Workflow to Profile Cellular Target Engagement of Kinase Inhibitors.

CellEKT: A Robust Chemical Proteomics Workflow to Profile Cellular Target Engagement of Kinase Inhibitors.

Journal: Molecular & cellular proteomics : MCP

Published: October 10, 2024

The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targets.

The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targets.

Journal: Cancer cell

Published: September 02, 2024

Insight in the (Phospho)proteome of Vascular Smooth Muscle Cells Derived From Patients With Abdominal Aortic Aneurysm Reveals Novel Disease Mechanisms.

Insight in the (Phospho)proteome of Vascular Smooth Muscle Cells Derived From Patients With Abdominal Aortic Aneurysm Reveals Novel Disease Mechanisms.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: August 29, 2024

Non-thermal plasma as promising anti-cancer therapy against bladder cancer by inducing DNA damage and cell cycle arrest.

Non-thermal plasma as promising anti-cancer therapy against bladder cancer by inducing DNA damage and cell cycle arrest.

Journal: Scientific reports

Published: July 31, 2024

msproteomics sitereport: reporting DIA-MS phosphoproteomics experiments at site level with ease.

msproteomics sitereport: reporting DIA-MS phosphoproteomics experiments at site level with ease.

Journal: Bioinformatics (Oxford, England)

Published: December 24, 2023

Phosphoproteomics of patient-derived xenografts identifies targets and markers associated with sensitivity and resistance to EGFR blockade in colorectal cancer.

Phosphoproteomics of patient-derived xenografts identifies targets and markers associated with sensitivity and resistance to EGFR blockade in colorectal cancer.

Journal: Science translational medicine

Published: August 16, 2023

EGFR/IGF1R Signaling Modulates Relaxation in Hypertrophic Cardiomyopathy.

EGFR/IGF1R Signaling Modulates Relaxation in Hypertrophic Cardiomyopathy.

Journal: Circulation research

Published: July 21, 2023

Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues.

Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues.

Journal: Molecular oncology

Published: July 19, 2023

The innate immune receptor NLRX1 is a novel required modulator for mPTP opening: implications for cardioprotection.

The innate immune receptor NLRX1 is a novel required modulator for mPTP opening: implications for cardioprotection.

Journal: Basic research in cardiology

Published: April 28, 2023

Candidate biomarkers for treatment benefit from sunitinib in patients with advanced renal cell carcinoma using mass spectrometry-based (phospho)proteomics.

Candidate biomarkers for treatment benefit from sunitinib in patients with advanced renal cell carcinoma using mass spectrometry-based (phospho)proteomics.

Journal: Clinical proteomics

Published: April 10, 2023

Showing 1-12 of 30

Last Updated: 09/26/2026